This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Hoslundia opposita
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
East and West African Lamiaceae herb used for epilepsy, malaria, and skin conditions.
East and West African Lamiaceae herb used for epilepsy, malaria, and skin conditions. Key active compounds include hoslundin, flavonoids, terpenoids.
hoslundin, along with flavonoids and terpenoids, are the primary bioactive compounds in Hoslundia opposita. These compounds disrupts microbial cell membranes and inhibits pathogen growth.
Anticonvulsant effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antimalarial properties
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antimicrobial
Epilepsy treatment in East African medicine
Based on traditional use; clinical evidence limited
Malaria remedy
Based on traditional use; clinical evidence limited
Skin conditions
Based on traditional use; clinical evidence limited
Antimicrobial use
Based on traditional use; clinical evidence limited
Found an error or have a correction for Hoslundia opposita?
Report an Issue →